Tyler-Stone Wealth Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Tyler-Stone Wealth Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-57	Closed	-$5K	–	980
2021 Q4	$5K	Buy	+57	New	+$3.75K	﹤0.01%	713

Tyler-Stone Wealth Management's ARNA Position: Q1 2022 in Review

Tyler-Stone Wealth Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 57 shares — an estimated $5K sold.

Tyler-Stone Wealth Management first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $5K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Tyler-Stone Wealth Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Tyler-Stone Wealth Management sold 57 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $5K.
Tyler-Stone Wealth Management first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Tyler-Stone Wealth Management's Arena Pharmaceuticals Inc position peaked at $5K in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Tyler-Stone Wealth Management's 13F filing for Q1 2022, filed 12 May 2022.